
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Inogen Inc (INGN)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: INGN (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $11
1 Year Target Price $11
1 | Strong Buy |
1 | Buy |
0 | Hold |
1 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -42.49% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 208.21M USD | Price to earnings Ratio - | 1Y Target Price 11 |
Price to earnings Ratio - | 1Y Target Price 11 | ||
Volume (30-day avg) 3 | Beta 1.72 | 52 Weeks Range 5.70 - 13.33 | Updated Date 08/14/2025 |
52 Weeks Range 5.70 - 13.33 | Updated Date 08/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.06 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-07 | When - | Estimate -0.27 | Actual -0.15 |
Profitability
Profit Margin -7.58% | Operating Margin (TTM) -6.64% |
Management Effectiveness
Return on Assets (TTM) -6.24% | Return on Equity (TTM) -13.46% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 104818003 | Price to Sales(TTM) 0.61 |
Enterprise Value 104818003 | Price to Sales(TTM) 0.61 | ||
Enterprise Value to Revenue 0.31 | Enterprise Value to EBITDA -17.6 | Shares Outstanding 27040400 | Shares Floating 23941832 |
Shares Outstanding 27040400 | Shares Floating 23941832 | ||
Percent Insiders 12.03 | Percent Institutions 72.63 |
Upturn AI SWOT
Inogen Inc

Company Overview
History and Background
Inogen Inc. was founded in 2001 in California. It designs, develops, manufactures, and markets portable oxygen concentrators (POCs) used by patients with chronic respiratory conditions. Initially, Inogen faced challenges in establishing its POC technology and market adoption, but has since become a significant player in the respiratory care market.
Core Business Areas
- POC Sales and Rentals: Inogen's primary business revolves around selling and renting its proprietary POCs. Sales involve direct-to-consumer channels and business-to-business channels such as hospitals, clinics, and distributors. Rentals offer patients a flexible option to use POCs without a full purchase.
- Services and Accessories: Inogen also offers services and accessories, including product maintenance, extended warranties, replacement parts, and oxygen supplies. These contribute to recurring revenue streams.
Leadership and Structure
The leadership team typically consists of a CEO, CFO, COO, and other key executives. The organizational structure follows a functional model with departments for research and development, manufacturing, sales, marketing, finance, and operations. The Board of Directors oversees the company's strategic direction.
Top Products and Market Share
Key Offerings
- Inogen One G5: The Inogen One G5 is a highly portable and lightweight oxygen concentrator with intelligent delivery technology. Inogen doesn't publicly provide market share data for specific products. However, Inogen and its main competitors, such as Philips Respironics and ResMed, vie for market share within the overall portable oxygen concentrator market. Competitors include ResMed (RMD), Philips (PHG), and Invacare (IVC).
- Inogen One G4: The Inogen One G4 is a smaller, more compact POC designed for users needing a highly discreet and portable solution. No specific market share data is available for this product. Competitors include ResMed (RMD), Philips (PHG), and Invacare (IVC).
Market Dynamics
Industry Overview
The respiratory care market is driven by the increasing prevalence of chronic respiratory diseases such as COPD and asthma, coupled with an aging population. The market is expanding due to technological advancements in POCs and growing demand for home healthcare solutions.
Positioning
Inogen positions itself as a leader in portable oxygen therapy, focusing on innovative, lightweight, and user-friendly POCs. Its competitive advantages lie in its proprietary technology, direct-to-consumer sales model, and brand reputation.
Total Addressable Market (TAM)
The global respiratory care devices market is projected to reach hundreds of billions of USD. Inogen is positioned to capture a significant portion of this market by focusing on portable oxygen concentrators and expanding its reach through various sales channels.
Upturn SWOT Analysis
Strengths
- Proprietary POC technology
- Direct-to-consumer sales model
- Lightweight and portable products
- Strong brand reputation
- Focus on innovation
Weaknesses
- Reliance on Medicare reimbursement
- High marketing and sales expenses
- Exposure to regulatory changes
- Concentration of revenue from few products
Opportunities
- Expanding international presence
- Developing new respiratory care products
- Strategic partnerships with healthcare providers
- Growing demand for home healthcare
- Increasing awareness of COPD and respiratory diseases
Threats
- Competition from larger medical device companies
- Changes in reimbursement policies
- Technological obsolescence
- Economic downturns affecting consumer spending
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- RMD
- PHG
- IVC
Competitive Landscape
Inogen's advantages include its lightweight and portable POCs, direct-to-consumer sales model, and strong brand reputation. Disadvantages include competition from larger medical device companies and reliance on reimbursement policies.
Growth Trajectory and Initiatives
Historical Growth: Inogen has historically experienced rapid growth due to increasing adoption of POCs and expansion of its sales channels. However, growth rates have fluctuated due to market conditions and competition.
Future Projections: Future growth projections depend on factors such as regulatory changes, competition, and market demand. Analyst estimates suggest continued growth in the respiratory care market, although specific projections for Inogen vary.
Recent Initiatives: Recent strategic initiatives may include expanding its international presence, developing new products, and strengthening its direct-to-consumer sales model. Check the company website for the latest strategic initiatives.
Summary
Inogen is a key player in the portable oxygen concentrator market, leveraging its proprietary technology and direct sales model. The company faces competition from larger firms and is susceptible to reimbursement policy changes. While Inogen's lightweight products and strong brand are strengths, managing costs and expanding internationally are vital for sustained growth. Inogen needs to look out for changes in government regulation and economic downturns that affect consumer spending.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Analyst estimates
- Company website (Inogen.com)
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data and financial metrics may be estimates and subject to change. Investing in stocks involves risks, and past performance is not indicative of future results. Please consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Inogen Inc
Exchange NASDAQ | Headquaters Goleta, CA, United States | ||
IPO Launch date 2014-02-14 | President, CEO & Director Mr. Kevin R. M. Smith | ||
Sector Healthcare | Industry Medical Devices | Full time employees 766 | Website https://www.inogen.com |
Full time employees 766 | Website https://www.inogen.com |
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.